Pirl

Talcum Powder linked to Ovarian Cancer

samantha severyn

The earliest research on the correlation between talcum powder and ovarian cancer dates to 1971 when scientists in Wales discovered particles of talc embedded in ovarian and cervical tumors. This was the first instance in which medical professionals realized women were at risk when using the powder on their genitals, sanitary pads, diaphragms, and in condoms. Despite the original findings and subsequent studies that have supported the original research, talc mining companies and Johnson & Johnson continue to argue against the connection citing insufficient evidence. The company has also managed to keep its product on the market without a warning for nearly half a century after the original discovery.

The first talcum powder ovarian cancer lawsuit was won against Johnson & Johnson in federal court in 2013. Since then, many women have pursued and continue to pursue talcum powder ovarian cancer lawsuits against the many manufacturers who produce it. Women claim the manufacturers were aware of the risks but hid information from customers to continue to increase profits.

Pirl is here to protect you! If you or a loved one has been a long-time user of Johnson & Johnson powder or any other talcum powder product and received an ovarian cancer diagnosis, you may be eligible for financial compensation.

Contact Pirl at info@mypirl.com 

*****A VITAL NOTE FROM THE PIRL TEAM: As we report on any medical product/medication case - NEVER STOP OR ALTER A MEDICAL PROGRAM OR COURSE OF MEDICATION WITHOUT CONSULTING YOUR(S) OR A PHYSICIAN.*****